IVIG for Infection Prevention After CAR-T-Cell Therapy
Condition: Lymphoma Interventions: Biological: Immune Globulin Infusion (Human), 10% Solution; Biological: Anti-CD19-targeting CAR-T Cells; Other: Saline; Procedure: Biospecimen Collection; Other: Survey Administration; Other: Electronic Health Record Review Sponsors: Fred Hutchinson Cancer Center; Takeda; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials